Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Analysis of Liquidity Ratios 

Microsoft Excel

Liquidity Ratios (Summary)

DexCom Inc., liquidity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Current ratio 1.99 5.11 5.58 5.47 7.64
Quick ratio 1.72 4.50 5.11 5.05 7.25
Cash ratio 1.34 3.79 4.41 4.26 6.23

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. DexCom Inc. current ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. DexCom Inc. quick ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. DexCom Inc. cash ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Current Ratio

DexCom Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Current assets 3,668,800 3,684,400 3,424,800 1,969,400 1,699,500
Current liabilities 1,839,300 720,800 614,100 360,200 222,400
Liquidity Ratio
Current ratio1 1.99 5.11 5.58 5.47 7.64
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.63 1.85 1.72 1.44
Cigna Group 0.73 0.83 0.77 0.74
CVS Health Corp. 0.94 0.88 0.91 0.94
Elevance Health Inc. 1.40 1.47 1.55 1.65
Humana Inc. 1.52 1.62 1.77 1.82
Intuitive Surgical Inc. 4.40 5.08 6.86 4.53
Medtronic PLC 1.86 2.65 2.13 2.59
UnitedHealth Group Inc. 0.77 0.79 0.74 0.69
Current Ratio, Sector
Health Care Equipment & Services 1.05 1.09 1.08 1.07
Current Ratio, Industry
Health Care 1.16 1.21 1.21 1.34

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 3,668,800 ÷ 1,839,300 = 1.99

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. DexCom Inc. current ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Quick Ratio

DexCom Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 642,300 1,052,600 817,600 446,200 1,137,000
Short-term marketable securities 1,813,900 1,678,600 1,890,100 1,087,100 248,600
Accounts receivable, net 713,300 514,300 428,500 286,300 226,700
Total quick assets 3,169,500 3,245,500 3,136,200 1,819,600 1,612,300
 
Current liabilities 1,839,300 720,800 614,100 360,200 222,400
Liquidity Ratio
Quick ratio1 1.72 4.50 5.11 5.05 7.25
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.06 1.28 1.14 0.88
Cigna Group 0.58 0.48 0.66 0.41
CVS Health Corp. 0.62 0.55 0.53 0.52
Elevance Health Inc. 1.27 1.33 1.42 1.52
Humana Inc. 1.20 1.20 1.37 1.47
Intuitive Surgical Inc. 3.56 4.34 5.96 3.75
Medtronic PLC 1.30 1.91 1.50 1.90
UnitedHealth Group Inc. 0.70 0.72 0.68 0.63
Quick Ratio, Sector
Health Care Equipment & Services 0.83 0.83 0.85 0.78
Quick Ratio, Industry
Health Care 0.86 0.90 0.90 1.00

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 3,169,500 ÷ 1,839,300 = 1.72

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. DexCom Inc. quick ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Cash Ratio

DexCom Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 642,300 1,052,600 817,600 446,200 1,137,000
Short-term marketable securities 1,813,900 1,678,600 1,890,100 1,087,100 248,600
Total cash assets 2,456,200 2,731,200 2,707,700 1,533,300 1,385,600
 
Current liabilities 1,839,300 720,800 614,100 360,200 222,400
Liquidity Ratio
Cash ratio1 1.34 3.79 4.41 4.26 6.23
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.66 0.78 0.60 0.38
Cigna Group 0.17 0.14 0.32 0.14
CVS Health Corp. 0.23 0.18 0.18 0.15
Elevance Health Inc. 0.86 0.95 1.04 1.08
Humana Inc. 1.10 1.08 1.29 1.37
Intuitive Surgical Inc. 2.90 3.66 5.30 3.13
Medtronic PLC 0.85 1.27 1.06 1.16
UnitedHealth Group Inc. 0.36 0.36 0.33 0.28
Cash Ratio, Sector
Health Care Equipment & Services 0.46 0.46 0.50 0.42
Cash Ratio, Industry
Health Care 0.48 0.52 0.53 0.64

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 2,456,200 ÷ 1,839,300 = 1.34

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. DexCom Inc. cash ratio deteriorated from 2020 to 2021 and from 2021 to 2022.